These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7441289)

  • 1. Abnormal distribution of lead in amyotrophic lateral sclerosis--reestimation of lead in the cerebrospinal fluid.
    Conradi S; Ronnevi LO; Nise G; Vesterberg O
    J Neurol Sci; 1980 Dec; 48(3):413-8. PubMed ID: 7441289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.
    Kapaki E; Segditsa J; Zournas C; Xenos D; Papageorgiou C
    Experientia; 1989 Dec; 45(11-12):1108-10. PubMed ID: 2599056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead in cerebrospinal fluid and its relationship to plasma lead in humans.
    Cavalleri A; Minoia C; Ceroni M; Poloni M
    J Appl Toxicol; 1984 Apr; 4(2):63-5. PubMed ID: 6736552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry.
    Conradi S; Ronnevi LO; Vesterberg O
    J Neurol Neurosurg Psychiatry; 1978 May; 41(5):389-93. PubMed ID: 77896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study.
    Vinceti M; Filippini T; Mandrioli J; Violi F; Bargellini A; Weuve J; Fini N; Grill P; Michalke B
    J Trace Elem Med Biol; 2017 Sep; 43():121-125. PubMed ID: 28089071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal tissue distribution of lead in amyotrophic lateral sclerosis.
    Conradi S; Ronnevi LO; Vesterberg O
    J Neurol Sci; 1976 Oct; 29(2-4):259-65. PubMed ID: 978210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead concentrations in blood, plasma, erythrocytes, and cerebrospinal fluid in amyotrophic lateral sclerosis.
    Stober T; Stelte W; Kunze K
    J Neurol Sci; 1983 Sep; 61(1):21-6. PubMed ID: 6631450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid (CSF) findings in amyotrophic lateral sclerosis.
    Leonardi A; Abbruzzese G; Arata L; Cocito L; Vische M
    J Neurol; 1984; 231(2):75-8. PubMed ID: 6737012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Total magnesium in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis].
    Iłzecka J; Stelmasiak Z; Kot A
    Neurol Neurochir Pol; 2000; 34(4):699-706. PubMed ID: 11105302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis.
    Iłecka J
    J Neural Transm (Vienna); 2004 Feb; 111(2):167-72. PubMed ID: 14767719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid angiogenin level in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Clin Croat; 2008 Jun; 47(2):77-9. PubMed ID: 18949901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromogranin A levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Verde F; Steinacker P; Oeckl P; Weishaupt JH; Rosenbohm A; Silani V; Ludolph AC; Otto M
    Neurobiol Aging; 2018 Jul; 67():21-22. PubMed ID: 29609078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.
    Kaiserova M; Grambalova Z; Otruba P; Stejskal D; Prikrylova Vranova H; Mares J; Mensikova K; Kanovsky P
    Acta Neurol Scand; 2017 Oct; 136(4):360-364. PubMed ID: 28185258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. Short communication.
    Matsuishi T; Nagamitsu S; Shoji H; Itoh M; Takashima S; Iwaki T; Shida N; Yamashita Y; Sakai T; Kato H
    J Neural Transm (Vienna); 1999; 106(9-10):943-8. PubMed ID: 10599876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    De Schaepdryver M; Jeromin A; Gille B; Claeys KG; Herbst V; Brix B; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):367-373. PubMed ID: 29054919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced lumbar cerebrospinal fluid corticotropin releasing factor (CRF) levels in amyotrophic lateral sclerosis.
    Klimek A; Cieślak D; Szulc-Kuberska J; Stepien H
    Acta Neurol Scand; 1986 Jul; 74(1):72-4. PubMed ID: 3490112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
    Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
    Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.